Latest News about AZN
Recent news which mentions AZN
2 Best Biotech Stocks to Buy Right Now
October 18, 2021
From Motley Fool
Here’s ‘one of the most bullish signals’ ever for bitcoin that many investors may have missed
October 18, 2021
From MarketWatch
Will AstraZeneca Have a Big Market for Its COVID-19 Therapy?
October 16, 2021
Tickers
AZN
From Motley Fool
The Daily Biotech Pulse: Moderna's Booster Shot Gets FDA Panel Backing, Decision Day For Avadel, Silence Therapeutics Strikes Licensing Deal, MiNK IPO
October 15, 2021
From Benzinga
The Smartest Stocks to Buy With $200 Right Now
October 15, 2021
From Motley Fool
2 Penny Stocks That Could Soar Soon
October 14, 2021
From Motley Fool
Is AstraZeneca Set to Soar With an Advanced Breast Cancer Treatment?
October 14, 2021
From Motley Fool
7 Foreign Stocks All U.S. Investors Should Be Watching
October 13, 2021
From InvestorPlace
The Daily Biotech Pulse: NRx Stitches COVID-19 Drug Partnership, Protara Gets Nod For Starting Bladder Cancer Study, IGM Moves Beyond Oncology
October 12, 2021
From Benzinga
AstraZeneca's COVID-19 Therapy Hits Goal In Phase 3 Trial
October 11, 2021
From Benzinga
Merck seeks authorization for what would be first pill to treat COVID-19, and AstraZeneca reports positive results for antibody treatment
October 11, 2021
From MarketWatch
Why the new SEC sheriff could be trouble for companies like Tesla
October 11, 2021
From MarketWatch
Why New COVID-19 Vaccination-Related Rules In This Australian State Have Small Businesses Worried
October 11, 2021
From Benzinga
Moderna Stock Looks Fully Valued Here, But It Has a Great Future
October 08, 2021
From InvestorPlace
Hopes that children will soon be eligible for Pfizer and BioNTech vaccine cheer parents, and Biden pushes vaccine requirements in Chicago
October 07, 2021
From MarketWatch
What Do Mix-and-Match Doses Mean for Vaccine Stocks?
October 07, 2021
From Motley Fool
Allowing people to mix COVID-19 vaccines could cut into Pfizer and Moderna’s revenue next year
October 06, 2021
From MarketWatch
Is This The Turning Point for Inovio?
October 06, 2021
From Motley Fool
Why Novavax Sank by Nearly 5% on Tuesday
October 05, 2021
From Motley Fool
Ocugen Bulls Are Overlooking Its FDA Approval Hurdles
October 05, 2021
From InvestorPlace
Positive news on COVID-19 vaccines and treatments in the U.S. weighs against Russia’s latest record one-day death toll
October 05, 2021
From MarketWatch
From Benzinga
The Daily Biotech Pulse: J&J Files For Booster Dose Authorization, Gemini Restructures, Strata Skin CFO Departs, Kaleido Reports Positive Readout
October 05, 2021
From Benzinga
From Benzinga
Bank of America turns bearish on European stocks, sees ‘anti-goldilocks’ shift ahead
October 01, 2021
Tickers
AZN
From MarketWatch
EMA's Risk Assessment Committee Finds Link Of Rare Cases Between JNJ COVID-19 Shot, Blood Clots
October 01, 2021
From Benzinga
The Daily Biotech Pulse: Merck Rallies On Antiviral Pill Data, Gilead Files For Yescarta Label Expansion, Exscientia IPO
October 01, 2021
From Benzinga
AstraZeneca COVID-19 Jab Shows 74% Efficacy In US Trial
September 30, 2021
From Benzinga
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.